These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2560436)

  • 1. [A preclinical evaluation of the antianginal activity of energy metabolism intermediates].
    Kostin VI
    Farmakol Toksikol; 1989; 52(6):49-52. PubMed ID: 2560436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Krebs cycle intermediates on the blood supply and energy metabolism of ischemic myocardium].
    Baĭramkulov KhD; Gatsura VV
    Biull Eksp Biol Med; 1978 Sep; 86(9):317-9. PubMed ID: 698378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of malate and NAD for the correction of the blood supply and oxygen balance of the acutely ischemic myocardium].
    Kostin VI
    Farmakol Toksikol; 1986; 49(3):44-6. PubMed ID: 3720933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The spectrum of the anti-ischemic activity of immobilized cytochrome c].
    Sernov LN; Ziuzina CV; Rozonov IuB; Belova LA; Gatsura VV
    Eksp Klin Farmakol; 1996; 59(2):12-4. PubMed ID: 8974554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Collateral coronary blood circulation and its role in the mechanism of the anti-ischemic (antianginal) action of pharmacologic preparations].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1989; 52(2):15-24. PubMed ID: 2663540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological approaches to the therapy of angina.
    Parratt JR
    Adv Drug Res; 1974; 9():103-34. PubMed ID: 4156950
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glycerinated myocardiocyte fibers in the rat myocardium as one of the models in a preclinical assessment of antianginal agents].
    Dzhanpoladian EG; Sambelian VM; Kaĭfadzhian MA; Tatinian NG; Khoetsian EL
    Biull Eksp Biol Med; 1989 Apr; 107(4):444-6. PubMed ID: 2720162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of Krebs cycle intermediates on the size of the necrotic zone and on the course of early postocclusion arrhythmia in experimental myocardial infarct in rats].
    Sernov LN; Snegireva GV; Gatsura VV
    Farmakol Toksikol; 1989; 52(6):47-9. PubMed ID: 2625147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of synthetic prostaglandin E1 on the cardiac blood supply and systemic hemodynamics in acute myocardial ischemia].
    Berger DIa; Pilipchuk DB; Sapozhkov AV; Freĭmanis IaF
    Farmakol Toksikol; 1989; 52(1):30-3. PubMed ID: 2707415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intermediators of the Krebs cycle and electron acceptor systems as new cardiac agents].
    Gatsura VV; Pichugin VV
    Vestn Akad Med Nauk SSSR; 1982; (5):34-8. PubMed ID: 7102091
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-anginal action of antihypoxants].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1986; 49(1):52-6. PubMed ID: 3948988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of neuroleptanalgesia agents on the collateral coronary circulation and systemic hemodynamics in acute myocardial ischemia].
    Iakushev MP; Sapozhkov AV
    Farmakol Toksikol; 1984; 47(4):59-62. PubMed ID: 6479313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The absence of a parallelism between the antihypoxic and anti-ischemic actions of pharmacological agents].
    Lomtadze DM; Tsorin IB; Chirkova EIu; Chichkanov GG
    Farmakol Toksikol; 1991; 54(3):27-9. PubMed ID: 1915815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antianginal drugs on myocardial energy metabolism in coronary artery disease.
    Bagger JP
    Pharmacol Toxicol; 1990; 66 Suppl 4():1-31. PubMed ID: 2181432
    [No Abstract]   [Full Text] [Related]  

  • 16. Exerimental evaluation of antianginal drugs.
    Esplugues J; Morcillo E; Badía A; Giraldez A; Bello R
    Rev Esp Fisiol; 1978 Mar; 34(1):15-20. PubMed ID: 663385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of dopamine on the systemic hemodynamic indices, on the blood supply of an ischemic focus and on the plasma enzyme activity in dogs with acute coronary occlusion].
    Katkov EV; Sysoliatina NA
    Farmakol Toksikol; 1989; 52(5):19-23. PubMed ID: 2599071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
    Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
    Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of the effect of different cardiovasotropic preparations on the contractility of separate sections of the myocardium in acute coronary occlusion].
    Kostin VI; Iakushev MP; Sapozhkov AV
    Farmakol Toksikol; 1985; 48(6):25-8. PubMed ID: 3936729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of the anti-anginal effect of korinfar].
    Voronkov LG; Sokolov NF
    Farmakol Toksikol; 1988; 51(5):38-41. PubMed ID: 3208884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.